Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIPHER Study in Early Stage Breast Cancer
NCT05333874Phase 1Active, not recruiting
- Sponsor
- Rutgers University
- Start
- Apr 2022
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial in breast cancer (2 arms), sponsored by Rutgers University. Primary endpoint: Detectable Circulating tumor DNA at 5 years. Started Apr 2022; status: active, not recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05333874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05333874.